• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CD70-targeting CAR-T cells have potential activity against CD19-negative B-cell Lymphoma.

作者信息

Deng Wenhai, Chen Panpan, Lei Wen, Xu Yang, Xu Nengwen, Pu Jeffrey J, Liang Aibin, Qian Wenbin

机构信息

Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.

Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, P. R. China.

出版信息

Cancer Commun (Lond). 2021 Sep;41(9):925-929. doi: 10.1002/cac2.12201. Epub 2021 Jul 27.

DOI:10.1002/cac2.12201
PMID:34313014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8441055/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3400/8441055/4d3ad26c1ba9/CAC2-41-925-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3400/8441055/4d3ad26c1ba9/CAC2-41-925-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3400/8441055/4d3ad26c1ba9/CAC2-41-925-g001.jpg

相似文献

1
CD70-targeting CAR-T cells have potential activity against CD19-negative B-cell Lymphoma.靶向CD70的嵌合抗原受体T细胞（CAR-T细胞）对CD19阴性B细胞淋巴瘤具有潜在活性。
Cancer Commun (Lond). 2021 Sep;41(9):925-929. doi: 10.1002/cac2.12201. Epub 2021 Jul 27.
2
T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies.针对 CD70 的 T 细胞用于治疗 CD70 阳性恶性肿瘤的免疫疗法。
Blood. 2011 Apr 21;117(16):4304-14. doi: 10.1182/blood-2010-04-278218. Epub 2011 Feb 8.
3
Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.人类遗传性CD70缺陷揭示了CD70 - CD27途径在抵抗爱泼斯坦 - 巴尔病毒感染免疫中的关键作用。
J Exp Med. 2017 Jan;214(1):73-89. doi: 10.1084/jem.20160784. Epub 2016 Dec 23.
4
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.CD70 反向信号增强了表达 CD27 的 B 细胞恶性肿瘤中 NK 细胞的功能和免疫监视。
Blood. 2017 Jul 20;130(3):297-309. doi: 10.1182/blood-2016-12-756585. Epub 2017 May 11.
5
TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma.转化生长因子-β上调CD70表达并诱导B细胞非霍奇金淋巴瘤中效应性记忆T细胞耗竭。
Leukemia. 2014 Sep;28(9):1872-84. doi: 10.1038/leu.2014.84. Epub 2014 Feb 26.
6
CD70-mediated CD27 expression downregulation contributed to the regulatory B10 cell impairment in rheumatoid arthritis.CD70 介导的 CD27 表达下调导致类风湿关节炎中调节性 B10 细胞功能障碍。
Mol Immunol. 2020 Mar;119:92-100. doi: 10.1016/j.molimm.2020.01.016. Epub 2020 Jan 30.
7
[The role and expression of CD27/CD70 in tonsil].CD27/CD70在扁桃体中的作用及表达
Nihon Jibiinkoka Gakkai Kaiho. 1998 Dec;101(12):1423-9. doi: 10.3950/jibiinkoka.101.12_1423.
8
CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma.CD70 作为嵌合抗原受体 T 细胞治疗头颈部鳞状细胞癌的靶点。
Oral Oncol. 2018 Mar;78:145-150. doi: 10.1016/j.oraloncology.2018.01.024. Epub 2018 Feb 20.
9
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors.双靶点 CAR-T 细胞（靶向 CD70 和 B7-H3）针对多种实体瘤表现出强大的临床前活性。
Theranostics. 2020 Jun 18;10(17):7622-7634. doi: 10.7150/thno.43991. eCollection 2020.
10
Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells.CD27-CD70共刺激途径在同种异体T细胞对滤泡性淋巴瘤细胞反应中的作用。
Br J Haematol. 1999 Jul;106(1):64-70. doi: 10.1046/j.1365-2141.1999.01474.x.

引用本文的文献

1
CD70 as a target in cancer immunotherapy: advances, challenges, and future directions.CD70作为癌症免疫治疗的靶点：进展、挑战与未来方向
Front Oncol. 2025 Aug 15;15:1609840. doi: 10.3389/fonc.2025.1609840. eCollection 2025.
2
Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06).基因亚型指导的免疫化疗用于复发难治性弥漫性大B细胞淋巴瘤：一项2期研究者发起的非随机临床试验（GUIDANCE-06）
Signal Transduct Target Ther. 2025 Jul 26;10(1):232. doi: 10.1038/s41392-025-02316-6.
3
CD70: An emerging target for integrated cancer diagnosis and therapy.

本文引用的文献

1
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity.CD70 特异性 CAR T 细胞对急性髓系白血病具有强大的活性，而没有造血干细胞毒性。
Blood. 2021 Jul 29;138(4):318-330. doi: 10.1182/blood.2020008221.
2
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors.双靶点 CAR-T 细胞（靶向 CD70 和 B7-H3）针对多种实体瘤表现出强大的临床前活性。
Theranostics. 2020 Jun 18;10(17):7622-7634. doi: 10.7150/thno.43991. eCollection 2020.
3
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma.
CD70：癌症综合诊断与治疗的新兴靶点。
Clin Transl Med. 2025 Jul;15(7):e70400. doi: 10.1002/ctm2.70400.
4
T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting.血液系统恶性肿瘤中的 T 细胞重定向疗法：为改善靶向性而开发的新策略和新进展。
Mol Ther. 2024 Sep 4;32(9):2856-2891. doi: 10.1016/j.ymthe.2024.07.028. Epub 2024 Aug 5.
5
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies.基于嵌合抗原受体（CAR）的乳腺癌免疫疗法：特点、正在进行的研究及未来策略。
Front Immunol. 2024 Apr 12;15:1385571. doi: 10.3389/fimmu.2024.1385571. eCollection 2024.
6
The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment.嵌合抗原受体 T 细胞针对肾细胞癌治疗的 CD70 的开发。
J Transl Med. 2024 Apr 18;22(1):368. doi: 10.1186/s12967-024-05101-1.
7
CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy.表达 IL-15 的 CD70 特异性 CAR NK 细胞用于治疗 CD19 阴性 B 细胞恶性肿瘤。
Blood Adv. 2024 Jun 11;8(11):2635-2645. doi: 10.1182/bloodadvances.2023012202.
8
Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-β signaling.肿瘤来源的外泌体通过外泌体CD19抗原诱导初始激活，但通过转化生长因子-β信号传导损害CD19特异性嵌合抗原受体T细胞的功能。
Front Med. 2024 Feb;18(1):128-146. doi: 10.1007/s11684-023-1010-1. Epub 2023 Oct 23.
9
Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy.历代优化：嵌合抗原受体T细胞（CAR-T）疗法的结构与生产进展
Cancers (Basel). 2023 Jul 3;15(13):3476. doi: 10.3390/cancers15133476.
10
Glutamine Metabolism Underlies the Functional Similarity of T Cells between Nile Tilapia and Tetrapod.谷氨酰胺代谢为尼罗罗非鱼和四足动物 T 细胞的功能相似性提供了基础。
Adv Sci (Weinh). 2023 Apr;10(12):e2201164. doi: 10.1002/advs.202201164. Epub 2023 Mar 8.
优化的串联 CD19/CD20 CAR 工程化 T 细胞治疗难治/复发 B 细胞淋巴瘤。
Blood. 2020 Oct 1;136(14):1632-1644. doi: 10.1182/blood.2020005278.
4
Engineering strategies to overcome the current roadblocks in CAR T cell therapy.克服 CAR T 细胞疗法当前障碍的工程策略。
Nat Rev Clin Oncol. 2020 Mar;17(3):147-167. doi: 10.1038/s41571-019-0297-y. Epub 2019 Dec 17.
5
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method.使用统一的免疫组织化学方法对多种实体瘤和血液肿瘤类型进行CD70表达筛查，作为潜在的患者分层方法。
Cancers (Basel). 2019 Oct 22;11(10):1611. doi: 10.3390/cancers11101611.
6
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19.嵌合抗原受体 T 细胞靶向 CD79b 在伴有或不伴有共靶向 CD19 的淋巴瘤中显示疗效。
Clin Cancer Res. 2019 Dec 1;25(23):7046-7057. doi: 10.1158/1078-0432.CCR-19-1337. Epub 2019 Aug 22.
7
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.接受淋巴细胞耗竭治疗对接受 CD19 CAR T 细胞治疗的侵袭性非霍奇金淋巴瘤患者的无进展生存期有影响。
Blood. 2019 Apr 25;133(17):1876-1887. doi: 10.1182/blood-2018-11-887067. Epub 2019 Feb 19.
8
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.一项 SGN-CD70A 治疗 CD70 阳性弥漫性大 B 细胞淋巴瘤和套细胞淋巴瘤患者的 1 期临床试验。
Invest New Drugs. 2019 Apr;37(2):297-306. doi: 10.1007/s10637-018-0655-0. Epub 2018 Aug 22.
9
Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.嵌合抗原受体中 4-1BB 共刺激会阻碍 T 细胞存活，且具有载体依赖性。
Cell Rep. 2017 Oct 3;21(1):17-26. doi: 10.1016/j.celrep.2017.09.015.
10
Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers.靶向表达CD70的癌症的嵌合抗原受体的临床前评估。
Clin Cancer Res. 2017 May 1;23(9):2267-2276. doi: 10.1158/1078-0432.CCR-16-1421. Epub 2016 Nov 1.